Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When is the expected fda decision date for apotex's ruxolitinib resubmission?What is the difference between apixaban and apixaban accord?When will tenofovir alafenide come off patent in canada?Does food increase lipitor's absorption?How does renal function impact tigecycline's liver safety?
See the DrugPatentWatch profile for tigecycline
Tigecycline (Tygacil) is given intravenously for complicated skin/skin structure infections, complicated intra-abdominal infections, or community-acquired bacterial pneumonia in adults. The typical regimen starts with a 100 mg loading dose, followed by 50 mg every 12 hours. Treatment duration is 5-14 days depending on the infection.[1]
Infuse each dose over 30-60 minutes. No dose adjustments for mild-to-moderate hepatic impairment, but reduce to 25 mg every 12 hours (after 100 mg load) for severe impairment. For end-stage renal disease or hemodialysis, no change needed as it's not primarily cleared by kidneys.[1]
Physicians adjust for drug interactions (e.g., warfarin increases INR) or if superinfection occurs. Tigecycline's broad-spectrum covers multidrug-resistant bugs like Acinetobacter, but higher mortality risk in ventilator-associated pneumonia limits its first-line use there.[1][2]
Nausea (26%) and vomiting (18%) are dose-related and most common; occur early, often managed with antiemetics. Avoid in pregnancy (Category D) due to fetal harm risk.[1] [1]: Tygacil Prescribing Information (Pfizer) [2]: FDA Label and Clinical Pharmacology Review
Other Questions About Tigecycline :